These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9914733)

  • 1. [Molecular biologic screening test (PCR) for fragile X syndrome].
    Kovács E; Morava E; Nádasi E; Czakó M; Melegh B; Kosztolányi G
    Orv Hetil; 1998 Dec; 139(52):3121-3. PubMed ID: 9914733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and molecular screening for fragile X syndrome in 300 patients with non-specific mental retardation].
    Jara L; López M; Mellado C; Aspillaga M; Avendaño I; Blanco R
    Rev Med Chil; 1998 Aug; 126(8):911-8. PubMed ID: 9830742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A methylation PCR approach for detection of fragile X syndrome.
    Panagopoulos I; Lassen C; Kristoffersson U; Aman P
    Hum Mutat; 1999; 14(1):71-9. PubMed ID: 10447261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new PCR assay useful for screening of FRAXE/FMR2 mental impairment among males.
    Santos CB; Costa Lima MA; Pimentel MM
    Hum Mutat; 2001 Aug; 18(2):157-62. PubMed ID: 11462240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.
    Mandel JL; Biancalana V
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S158-65. PubMed ID: 15135801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new approach to antenatal screening for Fragile X syndrome.
    Wald NJ; Morris JK
    Prenat Diagn; 2003 Apr; 23(4):345-51. PubMed ID: 12673644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study for the neonatal screening of fragile X syndrome.
    Rifé M; Mallolas J; Badenas C; Tazón B; Miguélez MR; Pàmpols T; Sànchez A; Milà M
    Prenat Diagn; 2002 Jun; 22(6):459-62. PubMed ID: 12116303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular diagnosis of Fragile X syndrome.
    Sofocleous C; Kolialexi A; Mavrou A
    Expert Rev Mol Diagn; 2009 Jan; 9(1):23-30. PubMed ID: 19099346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular diagnosis of fragile X syndrome with polymerase chain reaction: application of a diagnostic protocol in 50 families from northern Spain].
    Durán Domínguez M; Molina Carrillo M; Fernández Toral J; Martínez Merino T; López Arístegui MA; Alvarez Retuerto AI; Onaindía Urquijo ML; Tejada Mínguez MI
    An Esp Pediatr; 2001 Apr; 54(4):331-9. PubMed ID: 11273816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for fragile X syndrome.
    Murray J; Cuckle H; Taylor G; Hewison J
    Health Technol Assess; 1997; 1(4):i-iv, 1-71. PubMed ID: 9414543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular diagnosis and genetic counseling for fragile X mental retardation.
    Pandey UB; Phadke SR; Mittal B
    Neurol India; 2004 Mar; 52(1):36-42. PubMed ID: 15069237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathology of the fragile X syndrome.
    Tsongalis GJ; Silverman LM
    Arch Pathol Lab Med; 1993 Nov; 117(11):1121-5. PubMed ID: 8239933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragile X mental retardation syndrome: DNA diagnosis and carrier detection in New Zealand families.
    Neville L; Cochrane J; Fitzgerald P; Kennedy M
    N Z Med J; 1995 Oct; 108(1009):404-6. PubMed ID: 7478333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preimplantation diagnosis for fragile X syndrome based on the detection of the non-expanded paternal and maternal CGG.
    Sermon K; Seneca S; Vanderfaeillie A; Lissens W; Joris H; Vandervorst M; Van Steirteghem A; Liebaers I
    Prenat Diagn; 1999 Dec; 19(13):1223-30. PubMed ID: 10660959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A genetic and molecular study of 85 families affected with the fragile X syndrome].
    Milà Recasens M; Sánchez Díaz A; Glover López G; Castellví Bel S; Carbonell Meseguer P; Kruyer H; Ballesta Martínez F; Estivill Pallejà X
    An Esp Pediatr; 1996 Mar; 44(3):250-6. PubMed ID: 8830601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India.
    Guruju MR; Lavanya K; Thelma BK; Sujatha M; OmSai VR; Nagarathna V; Amarjyothi P; Jyothi A; Anandaraj MP
    J Clin Neurosci; 2009 Oct; 16(10):1305-10. PubMed ID: 19560928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplex methylation specific PCR analysis of fragile X syndrome: experience in Songklanagarind Hospital.
    Charalsawadi C; Sripo T; Limprasert P
    J Med Assoc Thai; 2005 Aug; 88(8):1057-61. PubMed ID: 16404832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple fragile X PCR assay with 7-deazaguanine-substituted DNA visualized by ethidium bromide.
    Cao J; Tarleton J; Barberio D; Davidow LS
    Mol Cell Probes; 1994 Apr; 8(2):177-80. PubMed ID: 7935515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal diagnosis and carrier screening for fragile X by PCR.
    Brown WT; Nolin S; Houck G; Ding X; Glicksman A; Li SY; Stark-Houck S; Brophy P; Duncan C; Dobkin C; Jenkins E
    Am J Med Genet; 1996 Jul; 64(1):191-5. PubMed ID: 8826474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust amplification and ethidium-visible detection of the fragile X syndrome CGG repeat using Pfu polymerase.
    Chong SS; Eichler EE; Nelson DL; Hughes MR
    Am J Med Genet; 1994 Jul; 51(4):522-6. PubMed ID: 7943034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.